Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cholecystokinin and Polypeptides

Research Papers that Mention the Interaction

These findings suggest: (i) CCK secretion is under feedback control by intraduodenal bile acids and to a lesser extent by pancreatic enzymes; (… of zero; (iii) gastrin secretion is feedback controlled via an indirect mechanism probably involving CCK‐induced somatostatin secretion; (iv) release of PP … CCK ; (v) CCK … in humans.
European journal of clinical investigation  •  1991  |  View Paper
However, the observation that physiological concentrations of CCK increase plasma levels of PP , and the finding that CCK receptor blockade selectively attenuates the postprandial increase in plasma PP concentrations support a physiological role for CCK in regulating PP secretion.
The Journal of clinical endocrinology and metabolism  •  1990  |  View Paper
Plasma pancreatic polypeptide (PP) levels were similarly decreased in five of the six subjects by 19-67% (P = 0.03) in line with the regulation of PP by CCK.
Cancer letters  •  1995  |  View Paper
The whey protein-enriched … plasma concentrations of cholecystokinin (CCK) at 60 and 75 min (P<0.05), glucagon-like peptide-1 (GLP-1) at ….001), peptide tyrosine–tyrosine (PYY) at 90 and 120 min (P<0.01) and pancreatic polypeptide ( PP ) from 15 to 120 …) compared with maltodextrin carbohydrate.
European Journal of Clinical Nutrition  •  2015  |  View Paper
This study provides evidence that CCK exerts an inhibitory effect on gastric acid secretion and plasma gastrin release as well as a stimulatory influence on the release of PP and somatostatin via CCK-A receptors but does not influence directly insulin or glucagon secretion in man.
Scandinavian journal of gastroenterology  •  1993  |  View Paper
Iv injection of cholecystokinin-8 elicited a small but significant increase in PP concentrations, while iv secretin did not increase PP concentrations at all in healthy subjects.
Acta endocrinologica  •  1993  |  View Paper
Exogenously administered PP in physiologic doses inhibits cholecystokinin and secretin-stimulated pancreatic secretion in vivo.
The Journal of surgical research  •  1986  |  View Paper
ICV administration of CCK-8 (1.0, 2.0, 4.0 micrograms) produced a rapid and transient elevation in plasma concentrations of PP.
Our results indicate that central administration of CCK-8 selectively elevated plasma PP concentration.
Endocrinology  •  1984  |  View Paper
The data suggest that in response to bombesin, cadmium has little or no effect on the release of gastrin, but that is exerts a latent effect on the release of both CCK and PP.
Biological Trace Element Research  •  2008  |  View Paper